Rapid pleurodesis for malignant pleural effusions
- PMID: 12796165
- DOI: 10.1378/chest.123.6.1895
Rapid pleurodesis for malignant pleural effusions
Abstract
Study objective: To determine the feasibility of rapid pleurodesis in patients with malignant pleural effusions in order to reduce hospital length of stay in patients with a limited life expectancy.
Design: Prospective case series.
Setting: Two university hospital programs.
Patients: Thirty-eight patients with symptomatic pleural effusions associated with malignancy.
Interventions: A 14F catheter was inserted percutaneously into the pleural space after radiographic confirmation of free fluid by lateral decubitus views. Following radiographic confirmation of complete fluid evacuation, a sclerosing agent (ie, talc slurry or bleomycin) was instilled into the pleural space. This was accomplished within 2 h of chest tube insertion, unless the tube was inserted in the evening or if the lung was trapped. After clamping the tube for 90 min, the pleural space was drained for 2 h, after which the chest tube was removed. The intervention was scored as "successful" if no radiographic evidence of fluid reaccumulation was noted at 4 weeks. A "partial successful" score indicated reaccumulation of fluid that did not produce symptoms and did not require repeat pleural drainage of any sort. All other outcomes were scored as "unsuccessful."
Measurements and results: Forty chest tubes were inserted into 38 patients. Four procedures revealed the presence of a trapped lung and did not result in any attempt at pleurodesis. Five patients who received pleurodesis died in less than 1 month and therefore were not evaluable. Two patients had technical problems with the chest tube and were not evaluable. Of the remaining 29 procedures, drainage procedures with pleurodesis were performed in 27 patients, a complete response was seen in 14 patients (48%), a partial response was seen in 9 patients (31%), and 6 patients (21%) did not respond to pleurodesis. Chemical pleurodesis was completed as an outpatient procedure in only two patients. In one of these, the outcome was unsuccessful. In the remainder, insertion of the chest tube in the evening or additional medical problems necessitated hospital admission, but the entire procedure was completed within 24 h.
Conclusions: Chemical pleurodesis can be accomplished with good results in < 24 h in the majority of patients with malignant pleural effusions.
Similar articles
-
Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion.Jpn J Clin Oncol. 1998 Mar;28(3):187-91. doi: 10.1093/jjco/28.3.187. Jpn J Clin Oncol. 1998. PMID: 9614441
-
Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter.Chest. 2000 Aug;118(2):417-21. doi: 10.1378/chest.118.2.417. Chest. 2000. PMID: 10936134
-
Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions.J Ultrasound Med. 2004 Sep;23(9):1171-6. doi: 10.7863/jum.2004.23.9.1171. J Ultrasound Med. 2004. PMID: 15328431
-
Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.Support Care Cancer. 2008 Dec;16(12):1323-31. doi: 10.1007/s00520-008-0405-5. Epub 2008 Feb 8. Support Care Cancer. 2008. PMID: 18259780 Review.
-
Management of malignant pleural effusions.Monaldi Arch Chest Dis. 2001 Oct;56(5):394-9. Monaldi Arch Chest Dis. 2001. PMID: 11887496 Review.
Cited by
-
Experience with Ambulatory Management of Pleural Pathologies Utilizing Small-Bore Indwelling Pleural Catheters.Cureus. 2017 Sep 1;9(9):e1636. doi: 10.7759/cureus.1636. Cureus. 2017. PMID: 29119067 Free PMC article.
-
Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial.J Thorac Dis. 2014 Dec;6(12):1731-5. doi: 10.3978/j.issn.2072-1439.2014.11.31. J Thorac Dis. 2014. PMID: 25589966 Free PMC article.
-
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.Curr Drug Discov Technol. 2016;13(2):68-76. doi: 10.2174/1570163813666160524142846. Curr Drug Discov Technol. 2016. PMID: 27216707 Free PMC article.
-
Patient evaluation for rapid pleurodesis of malignant pleural effusions.J Thorac Dis. 2016 Sep;8(9):2538-2543. doi: 10.21037/jtd.2016.08.55. J Thorac Dis. 2016. PMID: 27747006 Free PMC article.
-
Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study.Front Oncol. 2022 May 5;12:843220. doi: 10.3389/fonc.2022.843220. eCollection 2022. Front Oncol. 2022. PMID: 35600389 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources